Silence Therapeutics (SLN) Net Income (2024 - 2026)
Silence Therapeutics (SLN) posted Net Income of -$15.0 million for Q1 2026, down 27.08% sequentially from -$11.8 million in Q4 2025, and up 47.57% YoY from -$10.1 million in Q1 2025.
Silence Therapeutics (SLN) Net Income (2024 - 2026) Analysis & Trends
Silence Therapeutics has reported Net Income for 3 years, with the latest figure at -$15.0 million in Q1 2026.
- Quarterly Net Income rose 47.57% year-over-year to -$15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$75.0 million (down 25.98% YoY) and the FY2025 annual result came in at -$88.6 million, down 165.72% from the prior year.
- Net Income fell to -$15.0 million in Q1 2026 per SLN's latest filing, from -$11.8 million in the prior quarter.
- Over five years, Net Income peaked at $24.3 million in Q4 2024 and troughed at -$35.5 million in Q3 2024.
- A 3-year average of -$15.2 million and a median of -$19.8 million in 2024 frame the typical range for Net Income.
- The sharpest annual moves came in 2025 and 2026: Net Income tumbled 1134.0% in 2025, then jumped 47.57% in 2026.
- Over 3 years, Net Income stood at $24.3 million in 2024, then slumped by 148.51% to -$11.8 million in 2025, then dropped by 27.08% to -$15.0 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered -$15.0 million, -$11.8 million, and -$21.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 482.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 930.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -13.27 Mn |
| 10 | Silence Therapeutics | 648.22 Mn | 576.12 Mn | - | -12.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.27 Mn |
| Mar 31, 2026 | -14.96 Mn |
| Dec 31, 2025 | -11.77 Mn |
| Sep 30, 2025 | -20.96 Mn |
| Jun 30, 2025 | -27.35 Mn |
| Mar 31, 2025 | -28.53 Mn |
| Dec 31, 2024 | 24.26 Mn |
| Sep 30, 2024 | -35.54 Mn |
| Jun 30, 2024 | -19.76 Mn |
| Mar 31, 2024 | -2.31 Mn |